Associate Health Minister David Seymour says he is proud of the Government’s commitment to increasing medicines access for New Zealanders, resulting in a big uptick in the number of medicines being funded.
The data linkage approach has evidenced the benefit of a population register to facilitate equitable access to breast screening services. Further work is needed on choices of combined approaches for optimising screening uptake equitably.
Associate Health Minister with responsibility for Pharmac David Seymour is pleased to see Pharmac continue to increase availability of medicines for Kiwis with the government’s largest ever investment in Pharmac.
The proposal suggests broadening the range of people who can initiate treatment of stimulant medicines which, over time, would lead to more doctors and nurse practitioners being able to diagnose and treat ADHD.
The Government has recently announced its plan to modernise the regulation of medicines and medical devices by replacing the Medicines Act 1981 with a new Medical Products Bill (Bill). It has also decided that natural health products would be regulated under a standalone bill, yet to be developed.
The high rate of prescribing for probable gender dysphoria in New Zealand, and the decline after 2021, require further investigation.
New Zealand is prescribing up to seven times more puberty blockers to young transgender patients than other similar countries, new analysis shows.
Details of how and when Plunket nurses will step into providing childhood immunisations are still being finalised, say Plunket and Te Whatu Ora leaders.
Thousands of New Zealanders are failing to get proper screening for bowel cancer.
Pharmac is proposing to widen access to a medicine used in the treatment of chronic heart failure.
HEALTH SERVICES AND SYSTEMS
EQUITY
Exploring the impacts of the health system on minorities within the population, notably including Māori, Pacifica, Asians and LGBTQI.
DRUGS, DEVICE AND DIAGNOSTICS
PUBLIC HEALTH
DIGITAL HEALTH
TE TIRITI